The EAU regularly publishes press releases. Other news can be found in the News section or in the EAU News mailing. Stay up to date, and subscribe to the EAU Press Mailing List to receive the latest EAU press releases and other relevant information. Please subscribe here.
Madrid, 21 March 2015 – A new study shows how changing working methods in surgery can significantly reduce bacterial resistance to antibiotics, while maintaining protection against infection and reducing costs by up to 60%. This work is being presented at the European Association of Urology conference in Madrid.
Arnhem, 16 September 2015 – The European Prostate Cancer Awareness Day (EPAD) will take place for the first time on 16 September. This day, initiated by MEP Mr P. De Backer, Europa Uomo (the European prostate cancer coalition) and the European Association of Urology (EAU), aims to raise awareness, understanding and knowledge of the management of prostate diseases in general and prostate cancer in particular.
International radiological bodies* have agreed on a standard for how doctors evaluate MRI to confirm a diagnosis of prostate cancer. This promises to reduce the number of over diagnosis of insignificant cancers by to up to 89%. The new procedure also allows radiologists to identify up to 13% more life-threatening tumors than current procedures. The standards of how to acquire the MR-images and how to report them are published today** in the peer-reviewed journal, European Urology, the journal of the European Association of Urology.
The European Association of Urology, Europe’s largest community in the field of urology, is launching the virtual European Museum of Urology. The online museum brings together different European collections of urological objects, from private and public collections alike. By combining relatively small and geographically diverse collections, the European Museum of Urology offers one large collection featuring many rarities. The European Museum of Urology is the culmination of many years of work done by the EAU’s History Office.
Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after the age of 55, according to a new 20 year analysis of 6822 patients, presented at the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15) in Barcelona.
A rigorous evaluation of survival rates has shown that cancer patients with localised prostate cancer – the most common form of prostate cancer – have a better chance of survival if treated by surgery than by radiotherapy. These findings hold true even after accounting for type of radiation and the aggressiveness of cancer. This is the most robust analysis (meta-analysis) to date of published literature comparing surgery and radiotherapy for localised prostate cancer. The study is published in the peer-reviewed journal, European Urology.